medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2023, Número 2

<< Anterior Siguiente >>

Arch Neurocien 2023; 28 (2)


Neutrophil-lymphocyte and leuko-glycemic ratios as predictive markers for ventilatory support in patients with guillain-barre syndrome

Vargas-Cañas ES, Hernández-Sánchez MM, Galnares-Olalde JA, de Saráchaga AJ, Bazán-Rodríguez AL, May-Mas RN, López-Hernández JC

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 5-6
Archivo PDF: 308.66 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. López-Hernández JC, Colunga-Lozano LE, Garcia-Trejo S, Gomez-Figueroa E, et al. Electrophysiological subtypes and associated prognosisfactors of Mexican adults diagnosed with Guillain-Barré syndrome, asingle center experience. J Clin Neurosci. 2020, 80:292-7. doi:10.1016/j.jocn.2020.04.059

  2. van den Berg B, Storm EF, Garssen MJP, Blomkwist-Markens PH,Jacobs BC. Clinical outcome of Guillain-Barré syndrome afterprolonged mechanical ventilation. J Neurol Neurosurg Psychiatry. 2018Sep;89(9):949-54. doi: 10.1136/jnnp-2018-317968

  3. López-Hernández JC, Jorge de Saráchaga A, Briseño-Godínez ME, May-Mas RN, Bazán-Rodríguez L, León-Manriquez E, et al. Deltoid musclestrength and autonomic dysfunction as independent risk factors for invasivemechanical ventilation in patients with Guillain-Barré syndrome. Int JNeurosci. 2022; 27:1-13. doi: 10.1080/00207454.2022.2082963

  4. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF.Anticipating mechanical ventilation in Guillain-Barré syndrome. ArchNeurol. 2001 Jun;58(6):893-8. doi: 10.1001/archneur.58.6.893

  5. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P,Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solidtumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014May 29;106(6):dju124. doi: 10.1093/jnci/dju124

  6. Erre GL, Paliogiannis P, Castagna F, Mangoni AA, Carru C, Passiu G, etal. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyteratio in rheumatoid arthritis. Eur J Clin Invest. 2019; 49(1):e13037. doi:10.1111/eci.13037

  7. Dong CH, Wang ZM, Chen SY. Neutrophil to lymphocyte ratio predictmortality and major adverse cardiac events in acute coronary syndrome:A systematic review and meta-analysis. Clin Biochem. 2018; 52:131-6.doi: 10.1016/j.clinbiochem.2017.11.008

  8. Giede-Jeppe A, Bobinger T, Gerner ST, Sembill JA, Sprügel MI, BeuscherVD, et al. Neutrophil-to-lymphocyte ratio is an independent predictorfor in-hospital mortality in spontaneous intracerebral hemorrhage.Cerebrovasc Dis. 2017;44(1-2):26-34. doi: 10.1159/000468996

  9. Demirci S, Demirci S, Kutluhan S, Koyuncuoglu HR, Yurekli VA.The clinical significance of the neutrophil-to-lymphocyte ratioin multiple sclerosis. Int J Neurosci. 2016; 126(8):700-6. doi:

  10. 10.3109/00207454.2015.105049210. Martini R, Willison H. Neuroinflammation in the peripheral nerve:Cause, modulator, or bystander in peripheral neuropathies? Glia. 2016Apr;64(4):475-86. doi: 10.1002/glia.22899

  11. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria forGuillain-Barré syndrome. Ann Neurol. 1990; 27 Suppl:S21-4.

  12. M. Singer, Deutschman CS, Seymour CW, Shankar-Hari M, AnnaneD, Bauer M, et al. The Third International Consensus Definitions forSepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. doi:10.1001/jama.2016.0287

  13. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, ToykaKV, et al. Electrophysiological classification of Guillain-Barré syndrome:clinical associations and outcome. Plasma Exchange/SandoglobulinGuillain-Barré Syndrome Trial Group. Ann Neurol. 1998; 44(5):780-8.

  14. Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, SteyerbergEW, et al. Transparent Reporting of a multivariable prediction model forIndividual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.Ann Intern Med. 2015;162(1):W1-73. doi: 10.7326/M14-0698

  15. Hagen KM, Ousman SS. The neuroimmunology of Guillain-BarréSyndrome and the potential role of an aging immune system. Front AgingNeurosci. 2021 Jan 13;12:613628. doi: 10.3389/fnagi.2020.613628

  16. Orlikowski D, Sharshar T, Porcher R, Annane D, Raphael JC, Clair B.Prognosis and risk factors of early onset pneumonia in ventilated patientswith Guillain-Barré syndrome. Intensive Care Med. 2006;32(12):1962-9.

  17. Wang Y, Ju M, Chen C, Yang D, Hou D, Tang X, et al. Neutrophil-tolymphocyteratio as a prognostic marker in acute respiratory distresssyndrome patients: a retrospective study. J Thorac Dis. 2018;10(1):273-82. doi: 10.21037/jtd.2017.12.131

  18. Yu S, Arima H, Bertmar C, Clarke S, Herkes G, Krause M. Neutrophilto lymphocyte ratio and early clinical outcomes in patients with acuteischemic stroke. J Neurol Sci. 2018; 387:115-8. doi: 10.1016/j.jns.2018.02.002

  19. Ozdemir HH. Analysis of the albumin level, neutrophil-lymphocyte ratio, andplatelet-lymphocyte ratio in Guillain-Barré syndrome. Arq Neuropsiquiatr.

  20. 2016 Sep;74(9):718-22. doi: 10.1590/0004-282X2016013220. Huang Y, Ying Z, Quan W, Xiang W, Xie D, Weng Y, et al. The clinicalsignificance of neutrophil-to-lymphocyte ratio and monocyte-tolymphocyteratio in Guillain-Barré syndrome. Int J Neurosci. 2018;128(8):729-35. doi: 10.1080/00207454.2017.1418342

  21. Ning P, Yang B, Yang X, Huang H, Shen Q, Zhao Q, et al. Lymphocytebasedratios for predicting respiratory failure in Guillain-Barrésyndrome. J Neuroimmunol. 2021; 353:577504. doi: 10.1016/j.jneuroim.2021.577504

  22. Edriss H, Selvan K, Sigler M, Nugent K. Glucose levels in patients withacute respiratory failure requiring mechanical ventilation. J Intensive CareMed. 2017 Dec;32(10):578-84. doi: 10.1177/0885066616636013

  23. Wang Y, Li G, Yang S, Gu X, Li X, Liu M, et al. Fasting glucose levelscorrelate with disease severity of Guillain-Barré syndrome. PLoS One.2015 Dec 18;10(12):e0145075. doi: 10.1371/journal.pone.0145075

  24. Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: an update. Clin Auton Res. 2019; 29(3):289-99. doi:10.1007/s10286-018-0542-y

  25. León-Aliz E, Moreno-Martínez FL, Pérez-Fernández GA, Vega-Fleites LF,Rabassa-López-Calleja MA. Índice leuco-glucémico como marcadorpronóstico de la evolución intrahospitalaria en pacientes con infartoagudo de miocardio con elevación del ST [Leuko-glycemic index asan in-hospital prognostic marker in patients with ST-segment elevationmyocardial infarction]. Clin Investig Arterioscler. 2014; 26(4):168-75.doi: 10.1016/j.arteri.2014.01.002

  26. Hernández-Sánchez MM, Lozano-Nuevo JJ, Suárez-Cuenca JA,Mendoza-Portillo E, Vergara-Orduña FI, Palacios-Pérez E, et al. Índiceleuco-glucémico asociado con complicaciones en isquemia cerebralaterotrombótica. Med Int Méx. 2019; 35(1):39-44. doi: 10.24245/mim. v35i1.2180




2020     |     www.medigraphic.com